Drug Shortage Report for NAT-ESCITALOPRAM
Report ID | 75799 |
Drug Identification Number | 02440318 |
Brand name | NAT-ESCITALOPRAM |
Common or Proper name | Escitalopram Tablets |
Company Name | NATCO PHARMA (CANADA) INC |
Market Status | MARKETED |
Active Ingredient(s) | ESCITALOPRAM |
Strength(s) | 20MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | N06AB |
ATC description | ANTIDEPRESSANTS |
Reason for shortage | Requirements related to complying with good manufacturing practices. |
Anticipated start date | 2019-07-01 |
Actual start date | 2019-03-28 |
Estimated end date | Unknown |
Actual end date | 2020-10-01 |
Shortage status | Resolved |
Updated date | 2020-10-26 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2000 ARGENTIA ROAD, PLAZA 1, SUITE 200 MISSISSAUGA, ONTARIO CANADA L5N 1P7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v11 | 2020-10-26 | French | Compare |
v10 | 2020-10-26 | English | Compare |
v9 | 2019-04-17 | French | Compare |
v8 | 2019-04-17 | English | Compare |
v7 | 2019-03-29 | English | Compare |
v6 | 2019-03-28 | French | Compare |
v5 | 2019-03-28 | English | Compare |
v4 | 2019-02-15 | French | Compare |
v3 | 2019-02-15 | English | Compare |
v2 | 2019-02-15 | French | Compare |
v1 | 2019-02-15 | English | Compare |
Showing 1 to 11 of 11